Contribution of limbic norepinephrine to cannabinoid-induced aversion
RATIONALE: The cannabinoid system has risen to the forefront in the development of novel treatments for a number of pathophysiological processes. However, significant side effects have been observed in clinical trials raising concerns regarding the potential clinical utility of cannabinoid-based age...
Main Author: | |
---|---|
Other Authors: | , , , |
Format: | article |
Language: | eng |
Published: |
2010
|
Subjects: | |
Online Access: | http://hdl.handle.net/1822/29625 |
Country: | Portugal |
Oai: | oai:repositorium.sdum.uminho.pt:1822/29625 |